Literature DB >> 24444064

National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990 - 2013, study protocol.

Niloofar Peykari1, Sadaf Ghajarieh Sepanlou2, Shirin Djalalinia3, Amir Kasaeian4, Mahboubeh Parsaeian4, Alireza Ahmadvand4, Jalil Koohpayehzadeh5, Behzad Damari6, Hamid Reza Jamshidi7, Bagher Larijani8, Farshad Farzadfar3.   

Abstract

BACKGROUND: Non-communicable diseases (NCDs) and their risk factors are the major public health problems. There are some documented trend and point estimations of metabolic risk factors for Iranian population but there are little information about their exposure distribution at sub-national level and no information about their trends and their effects on the population health.
METHODS: The present study protocol is aimed to provide the standard structure definitions, organization, data sources, methods of data gathering or generating, and data on trend analysis of the metabolic risk factors in NASBOD study. We will estimate 1990 to 2013 trends of prevalence, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) and disability-adjusted life years DALYs for MRFs by gender, age group, and province. We will also quantify the uncertainty interval for the estimates of interest.
CONCLUSION: The findings of study could provide practical information regarding metabolic risk factors and their burden for better health policy to reduce the burden of diseases, and to plan cost-effective preventive strategies. The results also could be used for future complementary global, regional, national, and sub national studies.

Mesh:

Year:  2014        PMID: 24444064     DOI: 0141701/AIM.009

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  10 in total

1.  A multi-sectoral approach to combatting non-communicable diseases: Iran's experience.

Authors:  Niloofar Peykari; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2019-11-23

2.  The prevalence and predictors of pre-diabetes and diabetes among adults 40-70 years in Kharameh cohort study: A population-based study in Fars province, south of Iran.

Authors:  Masoumeh Ghoddusi Johari; Kimia Jokari; Alireza Mirahmadizadeh; Mozhgan Seif; Abbas Rezaianzadeh
Journal:  J Diabetes Metab Disord       Date:  2021-11-29

Review 3.  National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.

Authors:  Niloofar Peykari; Hassan Hashemi; Rasoul Dinarvand; Mohammad Haji-Aghajani; Reza Malekzadeh; Ali Sadrolsadat; Ali Akbar Sayyari; Mohsen Asadi-Lari; Alireza Delavari; Farshad Farzadfar; Aliakbar Haghdoost; Ramin Heshmat; Hamidreza Jamshidi; Naser Kalantari; Ahmad Koosha; Amirhossein Takian; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2017-01-23

4.  Spatio-Temporal Analysis of the Hepatitis B Prevalence in Iranian Blood Donors from 2000 to 2016 at National and Provincial Level.

Authors:  Negar Rezaei; Mahtab Maghsodlu; Ali Sheidaei; Sedigheh Amini Kafiabad; Kimiya Gohari; Maryam Zadsar; Farnaz Delavari; Zohreh Sharifi; Moein Yoosefi; Farshad Farzadfar; Mohsen Asadi-Lari
Journal:  Iran J Public Health       Date:  2021-09       Impact factor: 1.429

5.  Obesity researches in youth: A scientometrics study in Middle East countries.

Authors:  Mehrdad Kazemzadeh Atoofi; Mostafa Qorbani; Hamid Asayesh; Nazila Rezaei; Sahar Saeedi Moghaddam; Shirin Djalalinia
Journal:  J Res Med Sci       Date:  2021-08-30       Impact factor: 1.852

6.  High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25-64 Years Old Iranian Population.

Authors:  Niloofar Peykari; Moghaddam Sahar Saeedi; Shirin Djalalinia; Amir Kasaeian; Ali Sheidaei; Anita Mansouri; Younes Mohammadi; Mahboubeh Parsaeian; Parinaz Mehdipour; Bagher Larijani; Farshad Farzadfar
Journal:  Int J Prev Med       Date:  2016-05-19

7.  Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.

Authors:  Alireza Ahmadvand; Farshad Farzadfar; Hamid Reza Jamshidi; Naser Mohammadi; Kourosh Holakouie-Naieni
Journal:  Med J Islam Repub Iran       Date:  2015-09-09

8.  Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology.

Authors:  Shirin Djalalinia; Sahar Saeedi Moghaddam; Niloofar Peykari; Amir Kasaeian; Ali Sheidaei; Anita Mansouri; Younes Mohammadi; Mahboubeh Parsaeian; Parinaz Mehdipour; Bagher Larijani; Farshad Farzadfar
Journal:  Int J Prev Med       Date:  2015-11-04

9.  Inequality of obesity and socioeconomic factors in Iran: a systematic review and meta- analyses.

Authors:  Shirin Djalalinia; Niloofar Peykari; Mostafa Qorbani; Bagher Larijani; Farshad Farzadfar
Journal:  Med J Islam Repub Iran       Date:  2015-07-25

10.  Patterns of Obesity and Overweight in the Iranian Population: Findings of STEPs 2016.

Authors:  Shirin Djalalinia; Sahar Saeedi Moghaddam; Ali Sheidaei; Nazila Rezaei; Seyed Sina Naghibi Iravani; Mitra Modirian; Hossein Zokaei; Moein Yoosefi; Kimiya Gohari; Ahmad Kousha; Zhaleh Abdi; Shohreh Naderimagham; Ahmad Reza Soroush; Bagher Larijani; Farshad Farzadfar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-26       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.